TGTX
#1040
TG Therapeutics, Inc. - Common Stock
53.9 3 USD
-0.03%
Market Price
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
Rango anual
Cambio diario
-3.21%
Variación mensual
+0.88%
Variación en los últimos 6 meses
+83.50%
Cambio anual
+83.62%
Cierres anteriores
55.7 2
Open
53.9 3
Mínimo
53.9 3
Máximo
53.9 3
Volumen
115
Financials
- Market Capitalization 8.26 B
- Employee 399
- Founded 1993
- CEO Michael S Weiss
- Website www.tgtherapeutics.com
- Headquarter Delaware, United States
- FIGI BBG000FVZQY1
- Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
10.76
Relación precio/flujo de caja
7.81
Related tickers
| # | Nombre | Precio | 24h % | 7d % | 1M % | 1A % | Capitalización | Últimos 7 días | |
|---|---|---|---|---|---|---|---|---|---|
| 1014 |  IMVT Immunovant, Inc. - Common Stock | 41.20 USD | -5.98% | -6.36% | +6.71% | +114.47% | 8.51 B USD | ||
| 1024 |  APGE Apogee Therapeutics, Inc. - Common Stock | 134.97 USD | +0.01% | +0.13% | +0.54% | +151.86% | 8.40 B USD | ||
| 1057 |  SYRE Spyre Therapeutics, Inc. - Common Stock | 90.36 USD | -3.48% | -15.15% | -8.04% | +277.92% | 7.97 B USD | ||
| 1090 |  RYTM Rhythm Pharmaceuticals, Inc. - Common Stock | 107.17 USD | -4.76% | -4.56% | +1.60% | -2.85% | 7.38 B USD |